Brand-name vs compounded
Hers vs He & She MD: Brand-Name or Compounded? (2026)
Hers costs $1,788 a year against $1,980 for He & She MD. Full 2026 comparison of price, medication class and included support.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.8 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Hers and He & She MD sit at ranks 2 and 25 in our weight loss listing, which makes them close enough to be a genuine decision rather than an obvious one.
Hers dispenses brand-name, FDA-approved finished medication. He & She MD dispenses compounded medication prepared by a pharmacy rather than manufactured under an approved application. Those are different regulatory categories, and the price difference between them is the whole reason both business models exist.
Each program is read on its own published terms first, then against the other on the four things that decide satisfaction: price, predictability, formulary and access to a clinician. Undisclosed pricing is treated as a finding, not rounded into an estimate.
The short answer
- Lowest 12-month cost
- Hers — $1,788 against $1,980 at He & She MD, on each provider's own best published pricing.
- FDA-approved medication
- Hers — FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen — a finished product the FDA has reviewed, rather than a compounded preparation.
- Tirzepatide access
- He & She MD — Tirzepatide at $199/mo; the other side publishes semaglutide only.
- Widest medication choice
- He & She MD — compounded semaglutide injection, oral semaglutide and compounded tirzepatide injection.
Side-by-side comparison
Scan the pricing rows first, then the medication row. Those two settle most of these decisions between them.
| Hers | He & She MD | |
|---|---|---|
| Advertised price | Wegovy pill from $149/mo, injectable from $199/mo | Semaglutide from $139/mo, oral semaglutide and tirzepatide from $199/mo |
| Rate after promotions | $149/mo | $191/mo |
| Pricing structure | Published rate per medication | Introductory term, then renewal at a higher rate |
| Medication | FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen | Compounded semaglutide injection, oral semaglutide and compounded tirzepatide injection |
| Support model | Provider check-ins included | Coaching built into the plan |
| Shipping | Home delivery, no insurance required | Free expedited shipping with no upcharges |
| Price transparency | Published upfront | Published upfront |
| Tirzepatide | Not published | $199/mo |
| Patient reviews | 6,200 | 4,180 |
| eRxDoctor score | 9.8/10 | 7.0/10 |
The real cost: six months and twelve
Both providers lead with a number designed to get you through the intake. The figures underneath convert both offers into what you will have spent by month six and month twelve.
| Hers | He & She MD | |
|---|---|---|
| First month | $149 | $139 |
| Months 2 onward | $149/mo | $191/mo |
| 6-month total | $894 | $834 |
| 12-month total | $1,788 | $1,980 |
| Best published plan | No multi-month discount published | No multi-month discount published |
Over a year that is a $192 difference, in Hers's favor. Whether it is the right call depends on whether He & She MD gives you $16 a month of something you will use.
Price escalation to plan for: He & She MD moves from $139 to $191, a 37% increase. Set a calendar reminder for the month it changes.
Approved medication or compounded preparation
Hers dispenses FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen: an approved finished drug, meaning the agency has reviewed both the evidence behind it and the facility that makes it.
Across from that, He & She MD offers compounded semaglutide injection, oral semaglutide and compounded tirzepatide injection — prepared by a pharmacy rather than manufactured under approval. The price advantage and the reduced oversight are the same fact seen from two sides.
The honest framing is a trade, not a ranking. Compounded access is what has put GLP-1 treatment within reach of people whose insurance will not cover it; approved product is what removes a category of uncertainty about what is in the vial. Both of those are real.
Inside the Hers program
The pitch is brand-name Wegovy at a price that usually buys compounded medication elsewhere. Hers offers FDA-approved Wegovy® (brand-name semaglutide) with a personalized care team and ongoing dose check-ins, no compounded medications.
Practically: online intake with clinician review, home delivery, no insurance required, and a pricing model that is published rate per medication.
Ongoing care is personalized care team with ongoing dose check-ins, and the medication list runs to FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen.
Hers pros
- No insurance required
- FDA-approved brand-name Wegovy®, not a compounded product
- Personalized care team with ongoing dose check-ins
Hers cons
- No compounded/generic alternative offered
- Higher starting price than most compounded competitors
The reservation worth holding, particularly next to He & She MD: there is no compounded tier to fall back on if the brand-name price stops working for you.
He & She MD: what you are buying
He & She MD bundles compounded GLP-1 medication with a coaching app that carries 1:1 clinician messaging, GLP-1-specific guidance and progress tracking. Semaglutide injections start at $139/month, oral semaglutide and tirzepatide at $199/month, each a six-month introductory rate. Free expedited shipping, no membership fee, no insurance required. In this pairing, its distinguishing feature is three medication formats and a coaching app included, under a named board-certified obesity-medicine CMO.
Intake is 2-3 minute intake with no payment required to check eligibility. Fulfillment is free expedited shipping with no upcharges. The commercial terms are introductory term, then renewal at a higher rate, published upfront.
Behind the prescription sits coaching app with 1:1 clinician messaging and progress tracking, no extra charge. Available medication: compounded semaglutide injection, oral semaglutide and compounded tirzepatide injection.
He & She MD pros
- Fast 2-3 minute intake with no payment required to check eligibility
- No membership fee stacked on top of the medication price
- Free expedited shipping on every order, with no shipping upcharges
- Named, dual board-certified obesity-medicine Chief Medical Officer
He & She MD cons
- Compounded GLP-1s are not reviewed by the FDA for safety, efficacy or quality
- The 15-25 lbs in 12 weeks figure is self-reported retrospective data, not trial data
- Headline prices are 6-month intro rates that renew 30-45% higher
The cost of choosing this over Hers: the headline rates are six-month terms that renew 30-45% higher.
Who should choose Hers, and who should choose He & She MD
Choose Hers if:
- the monthly rate is the constraint — $149/mo against $191/mo
- you want an FDA-approved finished medication rather than a compounded preparation
- the twelve-month total is what you are optimizing ($1,788 against $1,980)
- the feature you would actually use: brand-name Wegovy at a price that usually buys compounded medication elsewhere
Choose He & She MD if:
- you want coaching app with 1:1 clinician messaging and progress tracking, no extra charge rather than a prescription alone
- you want tirzepatide available without changing provider later
- the level of clinical contact suits you: coaching app with 1:1 clinician messaging and progress tracking, no extra charge
- what it leads on is worth paying for in your case: three medication formats and a coaching app included, under a named board-certified obesity-medicine CMO
What each one gives up
On price. Hers is the cheaper program at $149/mo against $191/mo. What Hers gives up for that is there is no compounded tier to fall back on if the brand-name price stops working for you; what He & She MD charges for is three medication formats and a coaching app included, under a named board-certified obesity-medicine CMO.
On access. Hers advertises online intake with clinician review and home delivery, no insurance required; He & She MD advertises 2-3 minute intake with no payment required to check eligibility and free expedited shipping with no upcharges. Neither publishes its state coverage, so confirm you are eligible before paying for anything.
On predictability. Published rate per medication versus introductory term, then renewal at a higher rate. Whichever you pick, get the maintenance-dose price in writing at intake.
On clinical contact. The support models differ — personalized care team with ongoing dose check-ins against coaching app with 1:1 clinician messaging and progress tracking, no extra charge — and that difference is felt in week two, not week one.
The medication, not the platform
Neither Hers nor He & She MD manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.
In SURMOUNT-4, stopping tirzepatide after a lead-in period produced significant weight regain, where staying on it did not, per JAMA, SURMOUNT-4.
Take the clinical questions to the prescribing clinician at whichever platform you choose; take the pricing questions to their support team before you pay.
Hers vs He & She MD: common questions
Which is cheaper to start, Hers or He & She MD?
He & She MD, at $139 against $149. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
How fast can I start with Hers compared with He & She MD?
Hers advertises online intake with clinician review, with home delivery, no insurance required. He & She MD advertises 2-3 minute intake with no payment required to check eligibility, with free expedited shipping with no upcharges. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Can I switch from Hers to He & She MD later?
You can, and people do — usually when an introductory price expires. Budget for a repeat intake and a short overlap in supply, and confirm what happens to any unused portion of a multi-month plan before you cancel it.
Is Hers or He & She MD better for a first GLP-1 prescription?
For a first prescription, weight support over price. Hers offers more contact (personalized care team with ongoing dose check-ins), which matters most in the first eight weeks when side effects and titration questions are at their peak. Once you know how you tolerate the medication, the cheaper program becomes the rational choice.
What happens if I stop taking the medication?
Neither Hers nor He & She MD penalizes you for stopping, but the medication does. The published follow-up data on withdrawal shows substantial regain, which is why the twelve-month totals above matter more than either provider's introductory offer.
The verdict
Hers is the cheaper year by $192, and for a straightforward course of treatment that settles it.
The case for He & She MD is three medication formats and a coaching app included, under a named board-certified obesity-medicine CMO. That is worth $16 a month to some patients and nothing at all to others — be honest about which you are.
The failure mode here is not picking the wrong platform; it is stopping treatment because the bill moved. Choose the one whose bill you can predict.
Keep comparing
- Hers vs WellorithmBrand-name vs compounded
- Hers vs Ro.coBudget vs premium
- TMates vs He & She MDLocked price vs escalating price
- He & She MD vs MaximusLocked price vs escalating price
- Ro.co vs LIV BodyBrand-name vs compounded
- Ro.co vs NoviBrand-name vs compounded
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Hers or He & She MD, and does not sell treatment. Read our ranking methodology.